mTOR inhibition triggers mitochondrial fragmentation in cardiomyocytes through proteosome-dependent prohibitin degradation and OPA-1 cleavage

By sjmartinez • June 1, 2025

Verdejo HE, Parra V, Del Campo A, Vasquez-Trincado C, Gatica D, Lopez-Crisosto C, Kuzmicic J, Venegas-Zamora L, Zuñiga-Cuevas U, Troncoso MF, Troncoso R, Rothermel BA, Chiong M, Abel ED, Lavandero S. mTOR inhibition triggers mitochondrial fragmentation in cardiomyocytes through proteosome-dependent prohibitin degradation and OPA-1 cleavage. Cell Commun Signal. 2025 May 31;23(1):256. doi: 10.1186/s12964-025-02240-w. PMID: 40450326.

Tags: AMPK, Endocrinology, Mitochondrial fusion, mTOR, Oma1, OPA-1, Prohibitin, Publications, Rapamycin

Single-cell profiling reveals monocyte mitochondrial dysfunction in patients with cirrhosis progressing to acute-on-chronic liver failure

Wirtz TH, Palomino-Echeverria S, Pollmanns MR, Huergo E, Schreibing F, Reißing J, Sánchez-Garrido C, López-Vicario C, Aransay AM, Baldassare M, Zaccherini G, Pompili E, McCoy[...]

Genetic Correlates of Malignant Behavior in Aggressive Pituitary Tumors

Theodorou A, Benhamida J, Alano T, Armstrong D, Drodge S, Bellantoni M, Braun K, Chen J, Chow F, Drincic A, Goichot B, Heaney AP, Magge[...]

Beyond Mitochondrial Fission: Emerging Roles of Drp1 in Skeletal Muscle Physiology and Disease

Zou K, Berger NJ, Zhou Z, Kugler BA. Beyond Mitochondrial Fission: Emerging Roles of Drp1 in Skeletal Muscle Physiology and Disease. Am J Physiol Cell[...]